Ryuhei Hayashi

Professor

Osaka University Graduate School of Medicine

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Tissue Engineering Tissue Engineering professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Ryuhei Hayashi is a Professor at the Osaka University Graduate School of Medicine in Japan. His research focuses on the differentiation of human induced pluripotent stem cells and the generation of ocular tissues, as evidenced by his recent articles on extracellular vesicles, organoid generation, and single-cell transcriptomics. He also investigates genetic applications of CRISPR technology in creating knockout models for biomedical research. His work aims to advance understanding of ocular development and regenerative medicine.

Articles (7)

Year:

2025

Year:

2024

Year:

2022

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Sung-Joon Park

Laboratory Head

Kazusa DNA Research Institute

JAPAN

View details

Shun Shibata

Tohoku University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ryuhei Hayashi

Research Interests

Explore related searches

Contact this professor

About

Articles (7)

Extracellular vesicles from adipose-derived mesenchymal stem cells promote colony formation ability and EMT of corneal limbal epithelial cells

Single-cell transcriptomics reveals the molecular basis of human iPS cell differentiation into ectodermal ocular lineages

Generation of 3D lacrimal gland organoids from human pluripotent stem cells.

Cell-Type-Specific Adhesiveness and Proliferation Propensity on Laminin Isoforms Enable Purification of iPSC-Derived Corneal Epithelium.

Generation and validation of a PITX2–EGFP reporter line of human induced pluripotent stem cells enables isolation of periocular mesenchymal cells

Generation of knockout rabbits with X-linked severe combined immunodeficiency (X-SCID) using CRISPR/Cas9

Ocular surface ectoderm instigated by WNT inhibition and BMP4

Collaborators (2)

Sung-Joon Park

Shun Shibata

Make your next move.